SCHEMBL21883159

SCHEMBL21883159

CCOC(=O)c1ccn(C(=S)Nc2ccc(Cl)cc2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.54
MAPT P10636 4/20 0.48
GAA P10253 3/20 0.48
RECQL P46063 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
CRHBP P24387 1/20 0.48
CRHR2 Q13324 1/20 0.48
RAB9A P51151 5/20 0.48
NPC1 O15118 3/20 0.48
P2RY12 Q9H244 1/20 0.48
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 2/20 0.46
KMT2A Q03164 6/20 0.45
MEN1 O00255 5/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HTT P42858 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21807645 0.88 MAPT (0.47) MAPTGAARAB9ANPC1ALDH1A1
SCHEMBL32665832 0.86 POLB (0.55) MAPTRAB9ANPC1P2RY12ALDH1A1
SCHEMBL21883160 0.86 POLB (0.55) MAPTRAB9ANPC1P2RY12ALDH1A1
SCHEMBL21883158 0.81 KMT2A (0.52) MAPTGAATDP1RAB9ANPC1
SCHEMBL24221964 0.80 SMN1; SMN2 (0.47) MAPTGAARAB9ANPC1ALDH1A1
SCHEMBL21883512 0.76 PLAU (0.48) MAPTGAANPC1ALDH1A1KDM4E
SCHEMBL10436784 0.74 KMT2A (0.56) MAPTGAARAB9ANPC1ALDH1A1
SCHEMBL32665830 0.74 NPC1 (0.51) MAPTGAARAB9ANPC1ALDH1A1
SCHEMBL21883132 0.74 NPC1 (0.51) MAPTGAARAB9ANPC1ALDH1A1
SCHEMBL21883129 0.73 MEN1 (0.46) MAPTGAARAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534440-B2 Compounds with copper- or zinc-activated toxicity against microbial infection KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2026-01-27 US claimed
US-20220024877-A1 COMPOUNDS WITH COPPER- OR ZINC-ACTIVATED TOXICITY AGAINST MICROBIAL INFECTION THE UAB RESEARCH FOUNDATION 2022-01-27 US disclosed
WO-2020061412-A1 COMPOUNDS WITH COPPER- OR ZINC-ACTIVATED TOXICITY AGAINST MICROBIAL INFECTION KANSAS STATE UNIVERSITY RESEARCH FOUNDATION (US) 2020-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534440-B2 Compounds with copper- or zinc-activated toxicity against microbial infection TST, SLC39A11, SLC39A3 EGFR 632/4885MAPT 1521/4885GAA 2353/4885
US-20220024877-A1 COMPOUNDS WITH COPPER- OR ZINC-ACTIVATED TOXICITY AGAINST MICROBIAL INFECTION SLC39A11, CNBP, SLC39A3 EGFR 3464/4885MAPT 2375/4885GAA 2388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.